AURA17 study of osimertinib in Asia-Pacific patients (pts) with EGFR T790M-positive advanced non-small cell lung cancer (NSCLC): Updated phase II results including overall survival (OS)

Caicun Zhou, M. Wang, Ying Cheng, Y. Chen, Yanqiu Zhao, Yuankai Shi, Myung‐Ju Ahn, You Lü, Meiqi Shi, J. Y. Han,

Annals of Oncology · 2018 · 21 citations · 0 references

DOIFull text

Open access

Concepts